The 1100 square foot facility is scheduled to open in spring 2009. It will be housed in the Kansas City Biotechnology Development Center. The expansion will create 13 new jobs, to be phased in over three years.
The center will work with the KU Cancer Center to develop tests for identifying and characterizing cancer biomarkers.
"This partnership is expected to generate novel diagnostic and delivery systems and accelerate the commercialization of nanomaterials for in vitro and in vivo diagnostics in oncology and other medical fields," Luis Nunez, Chief Science Officer for BioTarget, said in a statement. "We're excited for the change to work with the University of Kansas, and we appreciate the support of the various economic development groups that helped make this project possible."